VeriMom¿Es kojic dipalmitate seguro durante el embarazo?
No harmonised reproductive classification was found for kojic dipalmitate and no peer‑reviewed evidence shows reproductive or teratogenic effects for the dipalmitate; the Cosmetic Ingredient Review concluded kojic acid (the parent) was not a reproductive toxicant and was safe at typical cosmetic use levels. Skin‑permeation work on formulations containing kojic dipalmitate shows measurable dermal penetration, so low but measurable systemic exposure is plausible. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21164073/))
Pregnancy-safe products containing kojic dipalmitate
Related ingredients
Frequently asked questions
- ¿Es kojic dipalmitate seguro durante el embarazo?
- No harmonised reproductive classification was found for kojic dipalmitate and no peer‑reviewed evidence shows reproductive or teratogenic effects for the dipalmitate; the Cosmetic Ingredient Review concluded kojic acid (the parent) was not a reproductive toxicant and was safe at typical cosmetic use levels. Skin‑permeation work on formulations containing kojic dipalmitate shows measurable dermal penetration, so low but measurable systemic exposure is plausible. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21164073/))
- ¿Es kojic dipalmitate seguro durante la lactancia?
- No data indicate reproductive toxicity or lactation/breastfeeding hazards for kojic dipalmitate; parental kojic acid was not found to be a reproductive toxicant in the CIR review. Because dermal absorption of dipalmitate/derived kojic acid is low but measurable in some formulations, low systemic exposure (and therefore potential minimal transfer to breastmilk) cannot be excluded but there is no direct evidence of harm. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/21164073/))
- ¿Es kojic dipalmitate seguro para la piel del bebé?
- No infant‑specific reproductive/developmental hazard data were identified for kojic dipalmitate. Given measurable dermal uptake in some formulations in adults, the exposure score for infants is increased by +1 (immature barrier and higher surface‑area‑to‑weight). There is no evidence that baby skin exposure causes developmental toxicity, but infant dermal exposure is plausibly higher than adult for ingredients with measurable absorption. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9959276/?utm_source=openai))
- ¿Cómo puntúa VeriMom a kojic dipalmitate?
- VeriMom puntúa kojic dipalmitate en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a kojic dipalmitate en el embarazo?
- Consulta nuestra lista de alternativas seguras a kojic dipalmitate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.